Green, Brian <br/><br/>
Metabolomics in Neurodegenerative Disease 

<br/><br/><br/>English[eng] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>glutamic acid||n/a||direct mass spectrometry||neurodegeneration||6-OHDA||targeted mass spectrometry||mitochondrial dysfunction||myo-inositol||metabolomics||bile acids||subacute mild traumatic brain injury||age-related macular degeneration||metabolic pathways||energy metabolism||midbrain||Alzheimer’s disease||biomarkers||1H NMR||Parkinson’s disease dementia||GC-MS||pathogenesis||tricarboxylic acid cycle||micro-dialysis||13C-labeled succinate||metabolism||lipidomics||dementia with Lewy bodies||fatty acid||prodromal Parkinson’s disease||malonate||cerebral ischemia||mass spectrometry||retinal pigment epithelium||excitotoxicity||endothelin-1||reperfusion||C. elegans||Streptomyces venezuelae||?-synuclein aggregates||natural product||fatty acid metabolism||imaging mass spectrometry||LC-MS||drusen||cerebral palsy||plasma||Parkinson’s disease